Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Psychopharmacology
|
December 17, 2002
Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle
C Grillon, J M P Baas
Journal of Behavior Therapy and Experimental Psychiatry
|
March 20, 2021
Trajectories of fear learning in healthy participants are able to distinguish groups that differ in individual characteristics, chronicity of fear and intrusions
N A Leen, P Duits, J M P Baas
Acta Psychologica
|
December 1, 2007
Failure to condition to a cue is associated with sustained contextual fear
J M P Baas, L van Ooijen, A Goudriaan, et al.
Behavioural Brain Research
|
August 14, 2014
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans
I Heitland, J L Kenemans, K B E Böcker, et al.
Neuroreport
|
April 3, 2002
Threat-induced cortical processing and startle potentiation
J M P Baas, J L Kenemans, K B E Böcker, et al.
Behavioural Brain Research
|
April 27, 2013
Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females
I Heitland, J L Kenemans, R S Oosting, et al.
Genes, Brain, and Behavior
|
December 9, 2015
Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter--revisited
I Heitland, L Groenink, J M van Gool, et al.
Nederlands Tijdschrift Voor Tandheelkunde
|
November 8, 2022
[Dental anxiety and alexithymia; research on anxiety acquisition]
N van der Zwaag, N A Leen, J M P Baas, et al.
Translational Psychiatry
|
September 27, 2012
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
I Heitland, F Klumpers, R S Oosting, et al.
Chronic Stress (Thousand Oaks, Calif.)
|
June 16, 2022
The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD
N A Leen, A D de Weijer, S J H van Rooij, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Psychopharmacology
|
December 17, 2002
Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle
C Grillon, J M P Baas
Journal of Behavior Therapy and Experimental Psychiatry
|
March 20, 2021
Trajectories of fear learning in healthy participants are able to distinguish groups that differ in individual characteristics, chronicity of fear and intrusions
N A Leen, P Duits, J M P Baas
Acta Psychologica
|
December 1, 2007
Failure to condition to a cue is associated with sustained contextual fear
J M P Baas, L van Ooijen, A Goudriaan, et al.
Behavioural Brain Research
|
August 14, 2014
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans
I Heitland, J L Kenemans, K B E Böcker, et al.
Neuroreport
|
April 3, 2002
Threat-induced cortical processing and startle potentiation
J M P Baas, J L Kenemans, K B E Böcker, et al.
Behavioural Brain Research
|
April 27, 2013
Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females
I Heitland, J L Kenemans, R S Oosting, et al.
Genes, Brain, and Behavior
|
December 9, 2015
Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter--revisited
I Heitland, L Groenink, J M van Gool, et al.
Nederlands Tijdschrift Voor Tandheelkunde
|
November 8, 2022
[Dental anxiety and alexithymia; research on anxiety acquisition]
N van der Zwaag, N A Leen, J M P Baas, et al.
Translational Psychiatry
|
September 27, 2012
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
I Heitland, F Klumpers, R S Oosting, et al.
Chronic Stress (Thousand Oaks, Calif.)
|
June 16, 2022
The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD
N A Leen, A D de Weijer, S J H van Rooij, et al.
Page
of 2